Related Experiment Video
Updated: Aug 5, 2026
03:22
Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
[Paget's disease: the prospects with ipriflavone]
D Bisbocci1, V Gallo, P Damiano
1Dipartimento di Medicina ed Oncologia sperimentale, Università, Torino.
Recenti Progressi in Medicina
|December 1, 1992
Summary
Ipriflavone effectively reduces pain and improves bone remodeling in Paget's disease patients. Higher initial doses may offer greater short-term benefits, suggesting a potential therapeutic strategy for this bone disorder.
Area of Science:
- Bone biology and pharmacology
- Clinical investigation of metabolic bone diseases
Background:
- Paget's disease is a chronic disorder marked by accelerated bone remodeling.
- Current treatments aim to manage symptoms and slow disease progression.
Purpose of the Study:
- To evaluate the efficacy of ipriflavone, a novel drug with dual action on bone resorption and deposition.
- To assess ipriflavone's impact on bone turnover markers and pain in Paget's disease patients.
Main Methods:
- A six-month study involving 20 patients with active Paget's disease.
- Patients received either 600 mg/day or 1200 mg/day of ipriflavone.
- Bone turnover markers (alkaline phosphatase, plasmatic BGP, urinary hydroxyproline/creatinine, urinary calcium) and pain were monitored.
Main Results:
- Ipriflavone demonstrated a rapid, dose-independent reduction in pain.
- Significant improvements in bone turnover markers were observed, particularly with the 1200 mg/day dosage after three months.
- After six months, both dosages showed comparable efficacy, with no significant differences.
Conclusions:
- Ipriflavone shows promise in managing Paget's disease, offering pain relief and influencing bone turnover.
- A higher initial dosage followed by a lower maintenance dose may be an effective treatment strategy.
- Further research is needed to confirm long-term efficacy and treatment persistence after discontinuation.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...